Home›Companies›Biotech & Pharma›Sonablate

Sonablate Corp.

Updated Oct 27, 2026·Latest SEC filing Aug 3, 2023·Suggest an edit

About Sonablate

Sonablate is a private company based in Charlotte, North Carolina, incorporated in 2021 in Delaware. It has reported $377,000 raised in one offering on Form D since August 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 12, 2023Aug 3, 2023$377,000of $60.0M target6$62,833Equity, Options, Securities on exerciseRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Sonablate's Form D filed Aug 3, 2023.

TM
RS
Ralph Seip
Executive officer
LT
Louis Ta
Corporate Secretary
RY
Richard Yang
Executive officer and director
HW
Hong Wei
Director
NS
Neal Sangani
Director
AG
Alejandro Gonzalez
Executive officer and director
BM
Bruce Murphy
Director

Sources

  1. SECSonablate Corp. filing history